Welcome to our dedicated page for Tate & Lyle Plc news (Ticker: TATYY), a resource for investors and traders seeking the latest updates and insights on Tate & Lyle Plc stock.
Tate & Lyle PLC (TATYY) is a global leader in food ingredient solutions with over 160 years of expertise in nutritional science and product innovation. This dedicated news hub provides investors and industry professionals with timely updates on financial performance, strategic initiatives, and technological advancements shaping the food ingredients sector.
Access comprehensive coverage of earnings announcements, product development milestones, and sustainability commitments. Our curated collection includes updates on manufacturing expansions, partnership agreements, and regulatory compliance developments relevant to Tate & Lyle's global market position.
Stay informed about innovations in sweetening systems, texture modification technologies, and nutritional enhancement solutions that drive the company's market leadership. This resource serves as your primary source for tracking operational updates and industry trends impacting TATYY's business trajectory.
Bookmark this page for streamlined access to Tate & Lyle's latest corporate communications and market-moving developments. Regularly updated content ensures you maintain current awareness of this food science innovator's evolving business landscape.
KPS Capital Partners has agreed to acquire Tate & Lyle's remaining 49.7% stake in Primient for $350 million, with the transaction expected to close by July 2024. Primient, founded in 1906, is a leading producer of plant-based, renewable food and industrial ingredients, employing 1,800 people across six facilities in the US and Brazil. KPS initially acquired a controlling interest in Primient in April 2022, and this new investment underscores its commitment to the company. KPS plans to modernize Primient's operations, with over $700 million allocated for capital investments over the next five years. The acquisition will be financed through a mix of equity and debt, with Barclays leading the debt financing.
KPS Capital Partners has announced a definitive purchase agreement to acquire a controlling stake in Tate & Lyle's Primary Products business in North America and Latin America for an enterprise value of $1.7 billion. This acquisition includes interests in Almidones Mexicanos and DuPont Tate & Lyle Bio-Products. KPS and Tate & Lyle will each own about 50% of the newly formed company, NewCo, with KPS having operational control. The transaction is expected to close in Q1 2022 and aims to drive growth opportunities and enhance profitability through substantial investment in NewCo.
FAQ
What is the current stock price of Tate & Lyle Plc (TATYY)?
What is the market cap of Tate & Lyle Plc (TATYY)?
